鞍重股份(002667.SZ):擬將領能鋰業51%股份轉讓至友鋰科技
格隆匯7月30日丨鞍重股份(002667.SZ)公佈,2022年7月29日,公司召開第六屆董事會第二十七次會議、第六屆監事會第二十三次會議,審議通過《關於控股子公司股權內部劃轉的議案》。為完善公司組織架構和管理體系,整合及優化公司戰略佈局,集合公司目前業務的地域優勢,提高經營管理效率,進一步優化公司內部資源和資產結構,助力鋰電新能源產業進行戰略性佈局,公司擬將持有的江西領能鋰業有限公司(“領能鋰業”)51%股份以對應的股權投資額轉讓至公司全資子公司宜春友鋰科技有限公司(“友鋰科技”)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.